Download PDF
Pneumologie 2001; 55(3): 135-143
DOI: 10.1055/s-2001-12282
ÜBERSICHT
Georg Thieme Verlag Stuttgart · New York

Therapieversagen bei ambulant erworbener Pneumonie

Ursachen und DifferenzialdiagnoseS. Ewig
  • Medizinische Universitätsklinik und Poliklinik II Bonn
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
   Permissions and Reprints

Einleitung

Das Therapieversagen bei Patienten mit einer ambulant erworbenen Pneumonie (AEP) stellt häufig ein schwieriges und wenig verstandenes klinisches Problem dar. Das Spektrum möglicher inadäquater Vorgehensweisen umfasst eine ausgedehnte und wenig gezielte Diagnostik auf der einen sowie eine antimikrobielle Polypragmasie und Übertherapie unter Verzicht auf eine genaue diagnostische Evaluation auf der anderen Seite. Daraus resultieren häufig unnötige Belastungen und Risiken für den Patienten, in jedem Fall aber vermeidbare hohe Kosten. Die folgende Übersicht stellt den Versuch dar, eine klinisch brauchbare Systematik der Ursachen des Therapieversagens und auf diesem Hintergrund Maßgaben für das konkrete differenzialdiagnostische Vorgehen zu erstellen.

Literatur

  • 1 American Thoracic Society . Guidelines for the initial management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, and initial antimicrobial therapy.  Am Rev Respir Dis. 1993;  148 1418-1426
    CrossrefPubMedGoogle Scholar
  • 2 Bartlett J G, Breiman R F, Mandell L A, File T MJ. Community-acquired pneumonia in adults: Guidelines for management.  Clin Infect Dis. 1998;  26 811-838
    CrossrefPubMedGoogle Scholar
  • 3 European study on community-acquired pneumonia (ESOCAP) committee . Guidelines for management of adult community-acquired lower respiratory tract infections.  Eur Respir J. 1998;  11 986-991
    CrossrefPubMedGoogle Scholar
  • 4 Schaberg T, Dalhoff K, Ewig S, Lorenz J, Wilkens H. (Deutsche Gesellschaft für Pneumologie) . Empfehlungen zur Therapie der ambulant erworbenen Pneumonie.  Pneumologie. 1998;  52 450-462
    PubMedGoogle Scholar
  • 5 Halm E A, Fine M J, Marrie T J, Coley C M, Kapoor W N, Obrosky D S, Singer D E. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.  JAMA. 1998;  279 1452-1457
    CrossrefPubMedGoogle Scholar
  • 6 Clinton M, Irwin G, Niederman M, Fein A. Relationship of risk factors to the radiological progression of community acquired pneumonia.  Am Rev Respir Dis. 1992;  145 A551
    PubMedGoogle Scholar
  • 7 Macfarlane J, Miller A, Smith W, Morris A H, Rose D E. Comparative radiographic features of community-acquired legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis.  Thorax. 1984;  39 28-33
    PubMedGoogle Scholar
  • 8 Marrie T. Normal resolution of community-acquired pneumonia.  Semin Respir Infect. 1992;  7 289-293
    PubMedGoogle Scholar
  • 9 Metlay J P, Fine M J, Schulz R, Marrie T J, Coley C M, Kapoor W N, Singer D E. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia.  J Gen Intern Med. 1997;  12 423-430
    CrossrefPubMedGoogle Scholar
  • 10 Metlay J P, Atlas S J, Borowsky L H, Singer D E. Time course of symptom resolution in patients with community-acquired pneumonia.  Respir Med. 1998;  92 1137-1142
    PubMedGoogle Scholar
  • 11 British Thoracic Society Research Commitee and The Public Health Laboratory Service . The aetiology, management and outcome of severe community acquired pneumonia on the intensive care unit.  Respir Med. 1992;  86 7-13
    CrossrefPubMedGoogle Scholar
  • 12 Fein A M, Feinsilver S H, Niederman M S, Fiel S, Pai P B. When pneumonia doesn't get better.  Clin Chest Med. 1987;  8 529-541
    PubMedGoogle Scholar
  • 13 Fein A M, Feinsilver S H, Niederman M S. Nonresolving and slowly resolving pneumonia. Diagnosis and management in the elderly patient.  Clin Chest Med. 1993;  14 555-569
    PubMedGoogle Scholar
  • 14 Feinsilver S H, Fein A M, Niederman M S, Schultz D E, Faegenburg D H. Utility of fiberoptic bronchoscopy in nonresolving pneumonia.  Chest. 1990;  98 1322-1326
    CrossrefPubMedGoogle Scholar
  • 15 Geppert E F. Chronic and recurrent pneumonia.  Semin Respir Infect. 1992;  7 282-288
    PubMedGoogle Scholar
  • 16 Kirtland S H, Winterbauer R H. Slowly resolving, chronic, and recurrent pneumonia.  Clin Chest Med. 1991;  12 303-318
    PubMedGoogle Scholar
  • 17 Ortqvist A, Kalin M, Lejdeborn L, Lundberg B. Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia.  Chest. 1990;  97 576-582
    CrossrefPubMedGoogle Scholar
  • 18 Minogue M F, Coley C M, Fine M J, Marrie T J, Kapoor W N, Singer D E. Patients hospitalized after initial outpatient treatment for community-acquired pneumonia.  Ann Emerg Med. 1998;  31 376-380
    PubMedGoogle Scholar
  • 19 Ewig S, Seifert K, Kleinfeld T, Göke N, Schäfer H. Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation.  Respir Med. 2000;  94 556-563
    PubMedGoogle Scholar
  • 20 Arancibia F, Ewig S, Martinez J M, Ruiz M, Bauer T, Mensa J, Torres A. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications.  Am J Respir Crit Care Med. 2000;  162 154-160
    CrossrefPubMedGoogle Scholar
  • 21 Ewig S, Torres A. Severe community-acquired pneumonia.  Clin Chest Med. 1999;  20 575-587
    CrossrefPubMedGoogle Scholar
  • 22 Torres A, Serra-Battles J, Ferrer A, Jimenez P, Celis R, Cobo E, Rodriguez-Roisin R. Severe community-acquired pneumonia. Epidemiology and prognostic factors.  Am Rev Respir Dis. 1991;  144 312-318
    CrossrefPubMedGoogle Scholar
  • 23 Leroy O, Santre C, Beuscart C, Georges H, Guery B, Jacquier J M, Beaucaire G. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit.  Intensive Care Med. 1995;  21 24-31
    CrossrefPubMedGoogle Scholar
  • 24 Ortqvist A, Hammers-Berggren S, Kalin M. Respiratory tract colonization and incidence of secondary infection during hospital treatment of community-acquired pneumonia.  Eur J Clin Microbiol Infect Dis. 1990;  9 725-731
    PubMedGoogle Scholar
  • 25 Schaberg T. on behalf of the Wiesbaden Study Group . The clinical failure rate of first-line antibiotic treatment is the key cost driver in the treatment of patients with more severe community-acquired lower respiratory tract infections.  Eur Respir J. 1998;  12 (Suppl. 28) 143s
    CrossrefPubMedGoogle Scholar
  • 26 Ewig S. Community-acquired pneumonia - Definition, epidemiology, and outcome.  Semin Respir Infect. 1999;  14 94-102
    PubMedGoogle Scholar
  • 27 Kuru T, Lynch J P III. Nonresolving or slowly resolving pneumonia.  Clin Chest Med. 1999;  20 623-651
    CrossrefPubMedGoogle Scholar
  • 28 Kresken M, Hafner D, Witte W, Reinert R R. Resistenzentwicklung bei Staphylokokken und anderen Gram-positiven Erregern gegenüber Chemotherapeutika im mitteleuropäischen Raum.  Chemother J. 2000;  9 (Suppl. 19) 5-14
    PubMedGoogle Scholar
  • 29 Kresken M, Hafner D. und die Studiengruppe . Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika in Mitteleuropa.  Chemother J. 2000;  7 51-86
    PubMedGoogle Scholar
  • 30 Kikuchi R, Watabe N, Konno T, Mishina N, Sekizawa K, Sasaki H. High incidence of silent aspiration in elderly patients with community-acquired pneumonia.  Am J Respir Crit Care Med. 1994;  150 251-253
    CrossrefPubMedGoogle Scholar
  • 31 Loeb M, McGeer A, McArthur M, Walter S, Simor A E. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities.  Arch Intern Med. 1999;  159 2058-2064
    CrossrefPubMedGoogle Scholar
  • 32 Nakagawa T, Sekizawa K, Arai H, Kikuchi R, Manabe K, Sasaki H. High incidence of pneumonia in elderly patients with basal ganglia infarction.  Arch Intern Med. 1997;  157 321-324
    CrossrefPubMedGoogle Scholar
  • 33 Matthay R A, Arroliga A C. Resection of pulmonary metastases.  Am Rev Respir Dis. 1993;  148 1691-1696
    PubMedGoogle Scholar
  • 34 Rodriguez J, Niederman M S, Fein A M, Pai P B. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease.  Am J Med. 1992;  93 29-34
    CrossrefPubMedGoogle Scholar
  • 35 Mason C M, Nelson S. Normal host defences and impairments associated with delayed resolution of pneumonia.  Semin Respir Infect. 1992;  7 243-255
    PubMedGoogle Scholar
  • 36 Jay S, Johanson W, Pierce A. The radiographic resolution of streptococcal pneumoniae pneumonia.  N Engl J Med. 1975;  293 798-801
    PubMedGoogle Scholar
  • 37 Mittl R L, Schwab R J, Duchin J S, Goin J E, Albeida S M, Miller W T. Radiographic resolution of community acquired pneumonia.  Am J Respir Crit Care Med. 1994;  149 630-635
    CrossrefPubMedGoogle Scholar
  • 38 Lynch P III, Sitrin R G. Noninfectious mimics of community caquired pneumonia.  Semin Respir Infect. 1992;  7 282-288
    PubMedGoogle Scholar
  • 39 Ewig S, Torres A. Flexible bronchoscopy for nosocomial pneumonia. As it stands today. Clin Chest Med 2000: (im Druck)
    Google Scholar
  • 40 Niederman M S. Bronchoscopy in nonresolving nosocomial pneumonia.  Chest. 2000;  117 212S-218S
    CrossrefPubMedGoogle Scholar
  • 41 Dunn I J, Marrie T J, MacKeen A D, Bhan V, Janigan D T. The value of open lung biopsy in immunocompetent patients with community-acquired pneumonia requiring hospitalization.  Chest. 1994;  106 23-27
    PubMedGoogle Scholar

Priv-Doz. Dr. med S Ewig

Medizinische Universitätsklinik und Poliklinik II

Sigmund-Freud-Straße 25
53105 Bonn

Email: E-mail: santiago.ewig@meb.uni-bonn.de